Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: 2020-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,827,057
Percent of class
2.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-017223
Form type
SC 13G/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Jul 10, 2020
Reporting period
Jun 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub